2107 Injection clinical trials

The Efficacy and Safety Study of 2107 Injection in Subjects With Mild to Moderate Knee Osteoarthritis

This study is testing a new injection, 2107, for knee arthritis against an existing treatment, DUROLANE®. We want to see if it helps reduce pain and is safe for people aged 40-80 with mild to moderate knee arthritis. It lasts 26 weeks.